Law360, New York (April 19, 2012, 6:43 PM ET) -- A drug shortage prevention system proposed by the generics industry has won the support of the Food and Drug Administration, which said Thursday that the information-sharing system would provide "exactly the data FDA needs" to fend off impending drug shortages.
The Generic Pharmaceutical Association's "accelerated recovery initiative" would have generic-drug makers send information about their production schedules for the next several months, as well as their on-site inventory and the inventory of their wholesalers, to the FDA, through a third party. The FDA could then use...
Generics Industry's Drug Shortage Plan Wins FDA Support
To view the full article, take a free trial now.
